Compare VRCA & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | HIT |
|---|---|---|
| Founded | 2013 | 1964 |
| Country | United States | United States |
| Employees | N/A | 80 |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.4M | 59.8M |
| IPO Year | 2018 | 2024 |
| Metric | VRCA | HIT |
|---|---|---|
| Price | $6.95 | $1.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $17.00 | $2.50 |
| AVG Volume (30 Days) | 153.8K | ★ 206.8K |
| Earning Date | 03-10-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $30,829,000.00 | $30,723,490.00 |
| Revenue This Year | $372.93 | $67.75 |
| Revenue Next Year | N/A | $29.85 |
| P/E Ratio | ★ N/A | $49.64 |
| Revenue Growth | ★ 234.73 | 55.15 |
| 52 Week Low | $3.28 | $0.51 |
| 52 Week High | $9.82 | $7.59 |
| Indicator | VRCA | HIT |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 29.57 |
| Support Level | $6.52 | $0.99 |
| Resistance Level | $7.84 | $1.50 |
| Average True Range (ATR) | 0.43 | 0.10 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 23.25 | 3.42 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.